Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
Beaumont researchers are hopeful that a combination treatment of two common drugs — naltrexone and ketamine will lessen the severity of COVID-19 symptoms by reducing the early and later side effects of the virus. Beaumont announced that the FDA has cleared them to launch a study named, “SINK COVID-19” (Study of Immunomodulation using Naltrexone and Ketamine for COVID-19). That and more in today’s Wayne County Daily Report.
Click here for entire report